Exchange: OTC·Updated 08:02 AM EDT

VVTMF VVT Med Inc.

$0.1568
$0.0429
(27.36%)
Pre-Market
Prev Close $0.1568
Mkt Cap$10.89M
Vol1.00

About VVTMF

VVT Med, Inc. develops, manufactures, and commercializes minimally invasive, non-thermal, and non-tumescent solutions for the treatment of varicose veins. Its product portfolio includes ScleroSafe and V-Block, which offer several competitive advantages over traditional treatments, such as shorter procedure times, reduced patient discomfort without the need for anesthesia, and faster recovery and visible results. The company was founded in 1969 and is headquartered in Vancouver, Canada.
50

Neutral Sentiment

How do you feel about VVTMF?

Advertisement|Remove ads.